EUVIMEDEUVIMED entdecken
Crossref

METTL14 downregulates GLUT9 through m6A methylation and attenuates hyperuricemia-induced fibrosis in mouse renal tubular epithelial cells

Jianan Yang, Tonglian Jiang, Xun Lu, Xiang Li, Xuling Zhou, Xinxin Guo, Chengxin Ma, Xiaobei Xie, Dongxiao Li, Siqi Yu, Jiayi An, Binghai Zhao und 1 weitere

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.113308 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Jianan Yang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Nephrosis Precision Medicine Innovation Center, Beihua University School of Basic Medical Science, Jilin 132011, Jilin, China; Department of Clinical…. Hauptthemen laut MEDLINE: Methyltransferases, Fibrosis, Hyperuricemia, Epithelial Cells. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jilin Provincial Science and Technology Department, Jilin Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hyperuricemia is a known risk factor for chronic kidney disease (CKD) and subsequent renal fibrosis. N6-methyladenosine (m6A) is the most prevalent chemical modification in eukaryotic mRNAs and has been implicated in various diseases. However, its role in hyperuricemic nephropathy (HN) remains unclear. This study investigated the involvement of the methylase METTL14 in HN pathogenesis. Our in vitro and in vivo function experiments demonstrated that METTL14 plays a crucial role in HN. In mouse models of uric acid (UA)-induced renal injury, we detected impaired kidney function, increased renal interstitial fibrosis, and significantly decreased m6A methylation levels in renal tissues. Treatment with benzbromarone, a UA-lowering drug, alleviated renal injury, restored m6A methylation levels, and upregulated METTL14 expression. Cellular experiments showed that METTL14 overexpression attenuated high UA-induced fibrosis in renal tubular epithelial cells. This overexpression significantly decreases the expression of GLUT9, a key protein involved in UA transport, leading to reduced UA reabsorption. Additionally, MeRIP-qPCR and dual-luciferase reporter gene experiments further demonstrated that METTL14 overexpression enhanced Glut9 mRNA m6A methylation modification, accelerating its degradation and decreasing expression levels. Thus, METTL14-mediated RNA m6A modification plays a role in the renal tubular epithelial cell damage induced by high UA, by regulating Glut9 mRNA post-transcriptionally. These findings provide valuable insights for the diagnosis and development of therapeutic drugs for HN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethyltransferasesFibrosisHyperuricemiaEpithelial CellsKidney TubulesAnimalsMiceMaleMethylationGlucose Transport Proteins, FacilitativeAdenosineMice, Inbred C57BLDown-RegulationCell LineUric AcidKidney DiseasesBenzbromaroneHumansDisease Models, Animal

Stichwörter der Autor:innen

GLUT9Hyperuricemic nephropathyMETTL14Renal fibrosisUrate reabsorptionm6A

Substanzen

MethyltransferasesMettl14 protein, mouseSlc2a9 protein, mouseGlucose Transport Proteins, FacilitativeAdenosineN-methyladenosineUric AcidBenzbromarone

Autor:innen und Institutionen

  • Nephrosis Precision Medicine Innovation Center, Beihua University School of Basic Medical Science, Jilin 132011, Jilin, China; Department of Clinical Laboratory, Beijing University of Chinese Medicine Third Affiliated H…
  • Nephrosis Precision Medicine Innovation Center, Beihua University School of Basic Medical Science, Jilin 132011, Jilin, China.
  • Nephrosis Precision Medicine Innovation Center, Beihua University School of Basic Medical Science, Jilin 132011, Jilin, China; Jilin Province Science and Technology Innovation Center of Kidney Disease Precision Medicine…

Förderung

  • National Natural Science Foundation of China
  • Jilin Provincial Science and Technology Department
  • Jilin Provincial Natural Science Foundation

Zitieren

APA

Yang, J., Jiang, T., Lu, X., Li, X., Zhou, X., Guo, X., Ma, C., Xie, X., Li, D., Yu, S., An, J., Zhao, B., & Li, H. (2024). METTL14 downregulates GLUT9 through m6A methylation and attenuates hyperuricemia-induced fibrosis in mouse renal tubular epithelial cells. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.113308

Vancouver

Yang J, Jiang T, Lu X, Li X, Zhou X, Guo X, et al. METTL14 downregulates GLUT9 through m6A methylation and attenuates hyperuricemia-induced fibrosis in mouse renal tubular epithelial cells. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.113308

BibTeX
@article{Yang2024,
  author = {Yang, Jianan and Jiang, Tonglian and Lu, Xun and Li, Xiang and Zhou, Xuling and Guo, Xinxin and Ma, Chengxin and Xie, Xiaobei and Li, Dongxiao and Yu, Siqi and An, Jiayi and Zhao, Binghai and Li, Hongzhi},
  title = {METTL14 downregulates GLUT9 through m6A methylation and attenuates hyperuricemia-induced fibrosis in mouse renal tubular epithelial cells},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.113308}
}
Kostenlos starten →